BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22705194)

  • 1. The effect of C1 inhibitor on myocardial ischemia and reperfusion injury.
    Lu F; Fernandes SM; Davis AE
    Cardiovasc Pathol; 2013; 22(1):75-80. PubMed ID: 22705194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of C1 inhibitor on intestinal ischemia and reperfusion injury.
    Lu F; Chauhan AK; Fernandes SM; Walsh MT; Wagner DD; Davis AE
    Am J Physiol Gastrointest Liver Physiol; 2008 Nov; 295(5):G1042-9. PubMed ID: 18787060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single administration of the CXC chemokine-binding protein Evasin-3 during ischemia prevents myocardial reperfusion injury in mice.
    Montecucco F; Lenglet S; Braunersreuther V; Pelli G; Pellieux C; Montessuit C; Lerch R; Deruaz M; Proudfoot AE; Mach F
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1371-7. PubMed ID: 20413731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-apoptotic role for C1 inhibitor in ischemia/reperfusion-induced myocardial cell injury.
    Fu J; Lin G; Wu Z; Ceng B; Wu Y; Liang G; Qin G; Li J; Chiu I; Liu D
    Biochem Biophys Res Commun; 2006 Oct; 349(2):504-12. PubMed ID: 16942749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Platelet GPVI Protects Against Myocardial Ischemia-Reperfusion Injury.
    Pachel C; Mathes D; Arias-Loza AP; Heitzmann W; Nordbeck P; Deppermann C; Lorenz V; Hofmann U; Nieswandt B; Frantz S
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):629-35. PubMed ID: 26916731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac Sirt1 mediates the cardioprotective effect of caloric restriction by suppressing local complement system activation after ischemia-reperfusion.
    Yamamoto T; Tamaki K; Shirakawa K; Ito K; Yan X; Katsumata Y; Anzai A; Matsuhashi T; Endo J; Inaba T; Tsubota K; Sano M; Fukuda K; Shinmura K
    Am J Physiol Heart Circ Physiol; 2016 Apr; 310(8):H1003-14. PubMed ID: 26873964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial ischemia and reperfusion injury is dependent on both IgM and mannose-binding lectin.
    Busche MN; Pavlov V; Takahashi K; Stahl GL
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1853-9. PubMed ID: 19749170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-ischemia/reperfusion of C1 inhibitor in myocardial cell injury via regulation of local myocardial C3 activity.
    Fu J; Lin G; Zeng B; Wu Z; Wu Y; Chu H; Qin G; Liang G; Li J; Gan X; Yu X; Li C; Liu D
    Biochem Biophys Res Commun; 2006 Nov; 350(1):162-8. PubMed ID: 16996480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The receptor for activated complement factor 5 (C5aR) conveys myocardial ischemic damage by mediating neutrophil transmigration.
    Mueller M; Herzog C; Larmann J; Schmitz M; Hilfiker-Kleiner D; Gessner JE; Theilmeier G
    Immunobiology; 2013 Sep; 218(9):1131-8. PubMed ID: 23642836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the complement and contact systems in the dextran sulfate sodium-induced colitis model: the effect of C1 inhibitor in inflammatory bowel disease.
    Lu F; Fernandes SM; Davis AE
    Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G878-83. PubMed ID: 20338925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo.
    Motoki A; Merkel MJ; Packwood WH; Cao Z; Liu L; Iliff J; Alkayed NJ; Van Winkle DM
    Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2128-34. PubMed ID: 18835921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnesium lithospermate B reduces myocardial ischemia/reperfusion injury in rats via regulating the inflammation response.
    Quan W; Wei G; Zhou D; Zhu Y; Guo C; Wang Y; Weng Y; Xi M; Wen A
    Pharm Biol; 2013 Nov; 51(11):1355-62. PubMed ID: 23863120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of self-reactive IgM significantly reduces injury in a murine model of acute myocardial infarction.
    Haas MS; Alicot EM; Schuerpf F; Chiu I; Li J; Moore FD; Carroll MC
    Cardiovasc Res; 2010 Sep; 87(4):618-27. PubMed ID: 20462867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo.
    Oerlemans MI; Liu J; Arslan F; den Ouden K; van Middelaar BJ; Doevendans PA; Sluijter JP
    Basic Res Cardiol; 2012 Jul; 107(4):270. PubMed ID: 22553001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selectin-targeting glycosaminoglycan-peptide conjugate limits neutrophil-mediated cardiac reperfusion injury.
    Dehghani T; Thai PN; Sodhi H; Ren L; Sirish P; Nader CE; Timofeyev V; Overton JL; Li X; Lam KS; Chiamvimonvat N; Panitch A
    Cardiovasc Res; 2022 Jan; 118(1):267-281. PubMed ID: 33125066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-α antagonism ameliorates myocardial ischemia-reperfusion injury in mice by upregulating adiponectin.
    Gao C; Liu Y; Yu Q; Yang Q; Li B; Sun L; Yan W; Cai X; Gao E; Xiong L; Wang H; Tao L
    Am J Physiol Heart Circ Physiol; 2015 Jun; 308(12):H1583-91. PubMed ID: 25888509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Lectin Pathway of Complement in Myocardial Ischemia/Reperfusion Injury-Review of Its Significance and the Potential Impact of Therapeutic Interference by C1 Esterase Inhibitor.
    Panagiotou A; Trendelenburg M; Osthoff M
    Front Immunol; 2018; 9():1151. PubMed ID: 29910807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs.
    Amsterdam EA; Stahl GL; Pan HL; Rendig SV; Fletcher MP; Longhurst JC
    Am J Physiol; 1995 Jan; 268(1 Pt 2):H448-57. PubMed ID: 7840295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Preclinical Translational Study of the Cardioprotective Effects of Plasma-Derived Alpha-1 Anti-trypsin in Acute Myocardial Infarction.
    Mauro AG; Mezzaroma E; Marchetti C; Narayan P; Del Buono MG; Capuano M; Prestamburgo A; Catapano S; Salloum FN; Abbate A; Toldo S
    J Cardiovasc Pharmacol; 2017 May; 69(5):273-278. PubMed ID: 28195949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement inhibition reduces injury in the type 2 diabetic heart following ischemia and reperfusion.
    La Bonte LR; Davis-Gorman G; Stahl GL; McDonagh PF
    Am J Physiol Heart Circ Physiol; 2008 Mar; 294(3):H1282-90. PubMed ID: 18178726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.